|
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 13.73 USD | -4.79% |
|
+3.98% | +3.31% |
| 13.07. | Pfizer und Astellas erhalten FDA-Zulassung für Blasenkrebs-Kombination | MT |
| 10.07. | Pfizer steht laut RBC vor einem gemischten zweiten Quartal | MT |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.53% | -3.95% | -5.36% | +19.26% | +6.90% | +50.70% | +152.78% | +365.87% | +1’278.83% | 1’024 Mrd. | |
| +0.21% | -2.68% | -2.54% | +12.84% | +23.87% | +53.20% | +50.87% | +48.81% | +105.33% | 618 Mrd. | |
| -2.51% | -3.25% | -3.88% | +21.46% | +9.83% | +28.54% | +67.99% | +117.36% | +275.77% | 443 Mrd. | |
| +0.06% | -0.42% | +3.54% | +11.06% | +7.74% | +37.53% | +31.06% | +0.48% | +44.09% | 349 Mrd. | |
| -0.14% | -0.24% | -1.11% | +9.23% | +15.51% | +34.41% | +39.49% | +51.13% | +58.95% | 297 Mrd. | |
| -0.69% | -0.30% | -13.11% | -6.51% | -8.40% | +13.76% | +13.84% | +52.67% | +152.54% | 264 Mrd. | |
| -7.37% | -4.40% | -7.68% | +10.25% | -5.76% | -0.74% | -43.66% | +5.53% | +65.45% | 209 Mrd. | |
| -0.64% | +2.43% | +2.94% | +16.78% | +17.67% | +29.74% | +67.16% | +60.62% | +121.17% | 208 Mrd. | |
| -0.82% | +0.70% | -0.81% | -1.09% | +6.09% | +15.05% | +72.05% | +90.50% | +63.64% | 162 Mrd. | |
| +0.40% | +1.92% | +2.84% | -5.01% | +0.44% | +6.47% | -29.25% | -43.11% | -31.27% | 143 Mrd. | |
| +0.69% | +5.19% | +12.35% | +12.18% | +21.08% | +47.66% | +5.77% | -3.98% | -12.98% | 133 Mrd. | |
| -0.95% | -0.05% | -9.65% | +12.54% | +5.24% | +3.24% | +33.12% | +140.57% | +381.24% | 121 Mrd. | |
| -0.44% | +0.63% | -3.62% | +1.60% | +5.86% | +38.31% | +41.25% | +8.24% | -8.57% | 104 Mrd. | |
| +2.34% | -2.05% | -1.04% | -6.70% | -9.97% | -7.31% | -21.50% | -14.16% | +0.76% | 103 Mrd. | |
| -3.39% | -2.09% | -12.26% | -17.17% | -18.66% | -8.19% | +61.49% | +67.46% | +442.18% | 71.57 Mrd. | |
| -2.23% | -6.55% | +0.60% | +1.53% | +11.50% | +27.78% | +23.56% | +47.62% | +14.17% | 55.24 Mrd. | |
| -0.81% | +4.32% | -9.95% | +26.28% | +29.83% | +70.87% | -7.60% | -4.87% | -48.99% | 54.3 Mrd. | |
| -1.04% | +1.18% | +1.10% | +0.37% | -9.22% | -11.79% | +27.91% | -2.12% | +232.84% | 52.81 Mrd. | |
| -1.44% | -0.06% | +0.80% | +5.58% | -3.07% | -0.57% | +12.95% | - | - | 43.08 Mrd. | |
| Durchschnitt | -0.89% | -0.54% | -2.46% | +6.55% | +5.60% | +22.56% | +31.54% | +54.92% | +174.17% | 234.45 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | -0.83% | -1.63% | -3.00% | +11.21% | +8.56% | +33.21% | +60.80% | +120.48% | +385.57% |
- Börse
- Aktien
- 856273 Aktie
- A0YGQP Aktie
- Sektor Astellas Pharma Inc.
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
